Mandalam Ramkumar's Form 4 filing
Cryoport, Inc. (CYRX) · filed Mar 19, 2024
- Accession no.
- 0001104659-24-036283
- Filed
- Mar 19, 2024
- Trade date
- Mar 15, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $47.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mandalam RamkumarCIK 0001611439 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | Common Stock | MOption exerciseAcquired | +8,334 | $5.40 | +$45,003.6 | 46,404 | Direct | |
| Mar 15, 2024 | Common Stock | SSaleDisposed | −3,217 | $14.68 | −$47,225.56 | 43,187 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | Common Stock | MOption exerciseDisposed | −8,334 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.